Evidence map›Paper›PMID 34491492›Full record

ArticleDocumenta ophthalmologica. Advances in ophthalmology2022

Subclinical maculopathy and retinopathy in transcobalamin deficiency: a 10-year follow-up.

Florence Rigaudière, Hala Nasser, Eliane Delouvrier, Paolo Milani, Manuel Schiff

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Documenta ophthalmologica. Advances in ophthalmology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Florence RigaudièreService de Physiologie Clinique. Explorations Fonctionnelles, DMU DREAM, Hôpital Lariboisière, AP-HP, Paris, France. rigaudiereflo@aol.com.ORCID 0000-0002-7369-7887
Hala NasserDépartement de Génétique, Hôpital Robert Debré, AP-HP, Paris, France.
Eliane DelouvrierService d'Ophtalmologie, Hôpital Robert Debré, AP-HP, Paris, France.
Paolo MilaniService de Physiologie Clinique. Explorations Fonctionnelles, DMU DREAM, Hôpital Lariboisière, AP-HP, Paris, France.
Manuel SchiffReference Center for Inborn Errors of Metabolism, Robert Debré Hospital, AP-HP, Paris, France.
Hôpital Robert-Debré · FRInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionTranscobalamin (TC) transports cobalamin (vitamin B SUBJECT: We report the electrophysiological results of one TC-deficient patient diagnosed at the age of 4 months immediately and continuosly treated by hydroxocobalamin IM. Her visual function was followed by eight ophthalmological assessments, eight flash-ERG, six EOG, one mf-ERG, and seven P-ERG recordings over a 10-year period, between the age of 2y 9 m and 12y 6 m.

resultsHer ophthalmological assessment including visual acuity, fundi, optical coherent tomography (OCT), and retinal nerve fiber layer (RNFL) remained normal. From the age of 2y 9 m to 5y, dark-adapted and light-adapted flash-ERGs, EOGs and pattern-ERG were normal. From the age of 6y 4 m to 12y 6 m, dark-adapted flash-ERGs and EOGs remained normal. Cone a-wave amplitudes remained normal, whereas cone b-wave and flicker-response amplitudes were decreased. At the age of 12y 6 m, mf-ERG N1P1 amplitudes on the central 30° were decreased. From the age of 7y 4 m to 12y 6 m, P-ERG P50 amplitudes were decreased with no N95. COMMENTS: While clinical and anatomical assessments remained normal over a 10-year period, patient's electrophysiological results suggested the progressive onset of a subclinical retinopathy of inner-cone dystrophy type, and a subclinical maculopathy on the central 30° including the ganglion cell layer deficiency on the central 15°, despite continuous intramuscular treatment, RPE and scotopic system remaining normal. The origins of such subclinical retinopathy and maculopathy are unknown and independent of early disease identification and aggressive intramuscular hydroxocobalamin therapy.

Indexed as

Macular DegenerationRetinal DiseasesChildChild, PreschoolElectroretinographyFemaleFollow-Up StudiesHumansHydroxocobalaminInfantTranscobalaminsVitamin B 12HydroxocobalaminTranscobalaminsVitamin B 12Ganglion cell deficiencyInner-cone dystrophyIntramuscular hydroxocobalamin treatmentRemethylation disordersSubclinical maculopathySubclinical retinopathyTC deficiencyTCN2 mutationsTranscobalamin deficiency

Identifiers

PMID34491492
OpenAlexW3198460311

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.